#Keynote866
#JensBedke presents #Keynote866 trial cis/gem/pembro vs chemo/placebo in muscle invasive #bladdercancer — higher pathCR but misses on EFS and OS.
@oncoalert @esmo #ESMO26
October 23, 2026 at 11:43 AM